>>>NP has said they get informed about serious adv
Post# of 148177
Clinically not ghoulishly, that info tells me that things are going well for the CYDY arm of the trial. The DSMB would not be continuing this trial if Leronlimab was seen to be harming trial participants. Conversely, the DSMB has an alternate decision to make; are the placebo participants being denied life saving therapy??
Read More: https://investorshangout.com/post/view?id=582...z6RnICkEBR